Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with tacrolimus
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Penson MG et al. | Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients. | 1999 | J. Heart Lung Transplant. | pmid:10452348 |
Jones JW et al. | Long-term survival of an extremity composite tissue allograft with FK506-mycophenolate mofetil therapy. | 1999 | Surgery | pmid:10455910 |
Miura S et al. | The beneficial effects of FK 506 on living-related renal transplantation in presensitized recipients. | 1999 | Transplant. Proc. | pmid:10455940 |
Jiang H and Kobayashi M | Differences between cyclosporin A and tacrolimus in organ transplantation. | 1999 | Transplant. Proc. | pmid:10455942 |
Kobashigawa JA | Postoperative management following heart transplantation. | 1999 | Transplant. Proc. | pmid:10455966 |
Hachida M et al. | Combined use of deoxyspergualin and FK 506 for temporary circulatory assist. | 1999 | Transplant. Proc. | pmid:10455968 |
Van Gelder RN and Kaplan HJ | Immunosuppression in uveitis therapy. | 1999 | Springer Semin. Immunopathol. | pmid:10457590 |
Drachenberg CB et al. | Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. | 1999 | Transplantation | pmid:10459544 |
Burke GA et al. | The role of early renal biopsy in cyclosporin induced thrombotic microangiopathy. | 1999 | Pediatr. Nephrol. | pmid:10460501 |
Morris-Stiff GJ et al. | Conversion from cyclosporin (Neoral) to tacrolimus (Prograf) in renal allograft recipients with chronic graft nephropathy: results of an observational study. | 1999 | Transpl. Int. | pmid:10460877 |
Gold BG | FK506 and the role of the immunophilin FKBP-52 in nerve regeneration. | 1999 | Drug Metab. Rev. | pmid:10461545 |
Arndt C et al. | Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. | 1999 | Microbiology (Reading, Engl.) | pmid:10463165 |
Wandel C et al. | P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies. | 1999 | Cancer Res. | pmid:10463589 |
Alexanian AR and Bamburg JR | Neuronal survival activity of s100betabeta is enhanced by calcineurin inhibitors and requires activation of NF-kappaB. | 1999 | FASEB J. | pmid:10463953 |
Shuto H et al. | Inhibition of GABA system involved in cyclosporine-induced convulsions. | 1999 | Life Sci. | pmid:10465348 |
Ivery MT | A proposed molecular model for the interaction of calcineurin with the cyclosporin A-cyclophilin A complex. | 1999 | Bioorg. Med. Chem. | pmid:10465413 |
Johnson CE and Truong NM | Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride. | 1999 Jul-Aug | J Am Pharm Assoc (Wash) | pmid:10467814 |
Ogino Y et al. | Comparison of cyclosporin A and tacrolimus concentrations in whole blood between jejunal and ileal transplanted rats. | 1999 | J. Pharm. Pharmacol. | pmid:10467956 |
Yokogawa K et al. | P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice. | 1999 | Pharm. Res. | pmid:10468022 |
Grassberger M et al. | A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology. | 1999 | Br. J. Dermatol. | pmid:10468798 |